|
Thu, 05/15/2025 - 01:07 |
Milestones III Surpasses $200M and Sets Bold New Goal |
Cystic fibrosis |
|
Tue, 05/13/2025 - 19:51 |
Cystic Fibrosis Foundation Urges Congress to Reject Harmful and Reckless Cuts to Medicaid |
Cystic fibrosis |
|
Wed, 04/02/2025 - 19:16 |
CF Foundation Responds to Mass Reductions in Force Across the FDA and NIH |
Cystic fibrosis |
|
Wed, 03/26/2025 - 04:09 |
CF Foundation Invests Up to $2.3 Million to Develop Test for Lung Infections |
Cystic fibrosis |
|
Fri, 03/21/2025 - 02:57 |
Cystic Fibrosis Foundation Celebrates New National Volunteer Advocacy Co-Chairs |
Cystic fibrosis |
|
Mon, 02/10/2025 - 21:51 |
CF Foundation Responds to the National Institutes of Health Announcement to Limit Funding for Indirect Costs |
Cystic fibrosis |
|
Wed, 08/07/2024 - 03:23 |
CF Foundation and Bakar Labs Announce 2024 Golden Ticket Winner |
Cystic fibrosis |
|
Thu, 08/01/2024 - 22:51 |
Cystic Fibrosis Foundation Announces 2024 Impact Grant Recipients |
Cystic fibrosis |
|
Sat, 05/25/2024 - 00:49 |
The Michael J. Fox Foundation Applauds Passage of National Plan to End Parkinsons Act in Congress |
The Michael J. ... |
|
Mon, 01/09/2023 - 23:19 |
Complimentary Webinar: Laboratory Diagnosis of Monkeypox Virus: Current and Upcoming Tests |
CloudLIMS |
|
Fri, 01/06/2023 - 04:21 |
Mobulous Technologies Developed India’s First Home Vaccination Mobile App - By Leading App Developers |
Mobuloustechnologies |
|
Fri, 12/23/2022 - 11:00 |
Gilead Enables Easier Veklury (Remdesivir) Access Through Retail and Specialty Pharmacies for Long-Term Care and Skilled Nursing Facilities |
Gilead Sciences |
|
Thu, 12/22/2022 - 18:42 |
Haiti: MSF supports cholera vaccination campaign amid outbreak |
Doctors Without... |
|
Wed, 12/21/2022 - 20:05 |
Cellectis Announces First Dosing of a Patient with its In-house Manufactured Product Candidate UCART22 for the treatment of r/r B-cell ALL |
Cellectis |
|
Wed, 12/21/2022 - 18:39 |
MSF trial finds better treatment for people with TB |
Doctors Without... |
|
Wed, 12/21/2022 - 14:38 |
Lexicon Announces Topline Results from Phase 2 Proof-of-Concept Study of LX9211 in Postherpetic Neuralgia |
Lexicon Pharmac... |
|
Wed, 12/21/2022 - 14:15 |
Heart Health Tip for Older Adults in 2023: Step it Up a Bit |
University of M... |
|
Wed, 12/21/2022 - 10:34 |
New Study Shows Western Region has Highest Prostate Cancer Mortality Among White Men in U.S.; Black Men Face Highest Prostate Cancer Mortality Overall |
American Cancer... |
|
Wed, 12/21/2022 - 06:11 |
Alnylam Submits CTA Application for ALN-KHK, an Investigational RNAi Therapeutic for the Treatment of Type 2 Diabetes |
Alnylam |
|
Wed, 12/21/2022 - 02:12 |
Decoding the secret language of photosynthesis |
UCR |
|
Tue, 12/20/2022 - 20:00 |
Gene therapy corrects mutation responsible for common heart condition, research shows |
UTSouthwestern |
|
Tue, 12/20/2022 - 08:55 |
MediGO is Latest Recipient of National Kidney Foundation Innovation Fund Investment |
National Kidney... |
|
Mon, 12/19/2022 - 22:01 |
SINOVAC's COVID-19 Vaccine Obtains the Official Pharmaceutical Product Registration in Hong Kong |
Sinovac Biotech |
|
Mon, 12/19/2022 - 19:41 |
EISAI TO DIVEST RIGHTS FOR ANTI-EPILEPTIC DRUG FYCOMPA (perampanel) CIII IN UNITED STATES TO CATALYST PHARMACEUTICALS |
EISAI |
|
Mon, 12/19/2022 - 19:31 |
Flu cases very high in Washington: DOH urges everyone take precautions |
Washington Stat... |
